These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33604532)

  • 1. ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis.
    To JC; Chiu AP; Tschida BR; Lo LH; Chiu CH; Li XX; Kuka TP; Linden MA; Amin K; Chan WC; Bell JB; Moriarity BS; Largaespada DA; Keng VW
    JHEP Rep; 2021 Apr; 3(2):100223. PubMed ID: 33604532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc finger protein ZBTB20 promotes Toll-like receptor-triggered innate immune responses by repressing IκBα gene transcription.
    Liu X; Zhang P; Bao Y; Han Y; Wang Y; Zhang Q; Zhan Z; Meng J; Li Y; Li N; Zhang WJ; Cao X
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11097-102. PubMed ID: 23776228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Wang Q; Tan YX; Ren YB; Dong LW; Xie ZF; Tang L; Cao D; Zhang WP; Hu HP; Wang HY
    BMC Cancer; 2011 Jun; 11():271. PubMed ID: 21702992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
    Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP
    J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
    Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C
    J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma.
    He Z; Zhu J; Mo J; Zhao H; Chen Q
    Mol Med Rep; 2020 Jul; 22(1):380-386. PubMed ID: 32319639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin.
    Tao J; Xu E; Zhao Y; Singh S; Li X; Couchy G; Chen X; Zucman-Rossi J; Chikina M; Monga SP
    Hepatology; 2016 Nov; 64(5):1587-1605. PubMed ID: 27097116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc finger and BTB domain-containing protein 20 aggravates angiotensin II-induced cardiac remodeling via the EGFR-AKT pathway.
    Li F; Du M; Yang Y; Wang Z; Zhang H; Wang X; Li Q
    J Mol Med (Berl); 2022 Mar; 100(3):427-438. PubMed ID: 34232352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
    Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
    Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
    Lachenmayer A; Alsinet C; Savic R; Cabellos L; Toffanin S; Hoshida Y; Villanueva A; Minguez B; Newell P; Tsai HW; Barretina J; Thung S; Ward SC; Bruix J; Mazzaferro V; Schwartz M; Friedman SL; Llovet JM
    Clin Cancer Res; 2012 Sep; 18(18):4997-5007. PubMed ID: 22811581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver.
    Xie Z; Zhang H; Tsai W; Zhang Y; Du Y; Zhong J; Szpirer C; Zhu M; Cao X; Barton MC; Grusby MJ; Zhang WJ
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10859-64. PubMed ID: 18669658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.
    Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L
    Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZBTB20-mediated titanium particle-induced peri-implant osteolysis by promoting macrophage inflammatory responses.
    Qiu J; Peng P; Xin M; Wen Z; Chen Z; Lin S; Kuang M; Fu Y; Fang G; Li S; Li C; Mao J; Qin L; Ding Y
    Biomater Sci; 2020 Jun; 8(11):3147-3163. PubMed ID: 32363359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
    Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
    Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transposon delivery for CRISPR-based loss-of-function screen in mice identifies NF2 as a cooperating gene involved with the canonical WNT signaling molecular class of hepatocellular carcinoma.
    Keng VW; Chiu AP; To JC; Li XX; Linden MA; Amin K; Moriarity BS; Yusa K
    Heliyon; 2023 Aug; 9(8):e18774. PubMed ID: 37576222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.